The First Scalable Organoid Platform
Reproducible organoid screening models at scale
NaviPlate is a novel 384-well plate for highly reproducible, mature organoid models.
The first of its kind, NaviPlate is automated, enabling high precision, scalable screening of drug candidates in organoid models.
Designed with user flexibility in mind, NaviPlate ensures early detection of lead candidates for optimised clinical development.
Low Cell Count Required - Suitable for patient-derived materials
User Friendly - No complex cell culture protocols
Flexible Models - Adaptable to desired model and assays
Easily Integrated - Compatible with standard equipment automations
Our First Indications
Renal
Cardiac
Oncology
Team
Dr Elad Katz
Dr Lindsay Davidson
Get In Touch
To find out more about our models and discuss your screen of interest, get in touch today.